Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
bolio@ He Did - and Zink !
https://news.sky.com/video/coronavirus-i-took-hydroxychloroquine-z-pack-and-zinc-for-china-virus-says-donald-trump-12056192
But corona mutates all the time (like normal flu's) so you can get another strain later - like the flu.
Dont usually do this - but the recent NWBO (OTC) story - inspires to tell that what I expect to be among the best long-term investments out there right now - that today made a $10 billion BO of IPHI and actually fell a little on the news. But MRVL (5G) is my most trusted investment for the future. IPHI up about 28%.
https://pro.oxfordclub.com/p/WEALTHTO99AGBBOOKOXFLT2YRDS786786LTBRK/WOXFWA25/?h=true
And you can take my word for' that it is MRVL - that's being announced at the video above (at that point at about 25$ where I came in).
Just realized that they have changed the video (the org. American Wealth Project - was about MRVL - for sure) - looking at new video myself - havent seen it myself before :)
Jasbg
gary@ No one says 'Sell right now' (not me anyway).
What we are saying (some of us) is that the company has to signal 'alive' and working 'for shareholder value' - including aggressively investigating BP BO - Europe BP Partner.
They need to give WS 'something' other - than 'Silence for Months'. Everyone can se how this is degrading value for company and shareholders.
As I said elsewhere to Amarin management:
You are in the Stock Market - 'Play the Game' - fellows.
Example of the total Madness of this WW pandemic - produced in a Chinese Bio Lab:
------------------------
1. Vascepa - not Yet on the table at FDA - why NOT ?
2. Remdesivir just Approved - has long list of bad side effects - at best reduces the recovery from Covid - some 3 - 4 days - costs $3200 for a treatment.
https://www.drugs.com/veklury.html
3. HCQ - Not Approved by FDA - the most used and effective treatment for Covid (with Zink - and antibiotic) - used WW - except USA and parts of Vestern Europe (for political reasons) - cost a few dollars.
https://www.drugs.com/hydroxychloroquine.html
-----------------------
Se in the video with a true Hero emerging from this terrible pandemic - why this is Complete Madness - created in a group of greedy BP's - WHO - Fauci - CDC - FDA. One of the most 'cynical and shameful shams' made on human race in history.
THE TRUTH - about Remdesivir and HCQ - listen from 13 minnutes in and forward some 5- 6 minnutes:
johnh@ I have repeated many times - if we haven't lost patent trial - and SP were right now $40 - 60 JT would be considered a business God - no one would even notice or be interested in how he talks.
I like you appreciate his 'down to earth' style - always talking facts.
Get your point - all to well !
Pharm@ I agree with you - some 50% - and have never supported the smearing of JT or any other Amarin employee for that matter. I would like an explanation: Why the 9th Circuit - but that's all water under the bridge now.
--------------------------------
I don't agree with you in the 'hide in the cave part' - waiting to see what Generic do.
This is not how business works' - You wait to se what competitors do' you are already hopeless behind. Amarin has (should have) informed Bio press - Financial press - about plan B - C - if legal case is lost (which it most likely is).
Instead they have been hiding in a hole - doing NOTHING - to support the SP - since the disaster ruling in Marts 2020.
Generic Hikma (590 products) about 19.000 employees - Dr. Reddy - +190 products - about 29.000 employees - this is daily routine for them. They have cases like this all the time - this is 'What they do - How they operate' - they do not care one bit 'What Amarin does' - for it's survival. It's business for them.
---------------------------------
So the Idea' that Amarin 'has to hide' Not to give their Move away - is absolute nonsense. The Company has to face the 'Nev reality' - that generic bloodhound lawyers Won the first 2 rounds (most likely the game) for US Brand Vascepa market.
Of course they should follow up on 'the very small chance of Reversal' - but at the same time - They have to 'Move On' - facing the new realty Head On. Give the market 'Something' to regain some sort of trust/believe in that this Company is not dead/beaten.
No one could ever blame Amarin for 'public announcing' that the company is aggressively working on a BO with a number of BP's - so why 'don't they'. It would not cost a penny' The Market would love it - instead of the ever 'No Milk today - News today message' for Months and Months.
Trip@ The first insider (and a Real insider - you would think have connections to the top of Co.).
I agree - this could be a strong signal - that 'things are on the table at Amarins' :)
LOt@ What is your suggestions then ?
Or do you think the current state of Amarin - is where we should/ought to be ?
P-file@ Didn't mean you specific - calling names.
And fair enough' you did not - but looking a bit around post's here you will not be long before - understanding what is referred to'.
P@ Only problem is that Furious - doesn't solve anything for anyone.
If you have a constructive way (you and others) to get JT to step down 'USE IT' - but please stop calling a man than won several prices for great leadership in 2018 - al kind of childish names.
A bit funny 'that it is often the 'Super Gamblers in Options' that the most aggressive. As I said before - they should stick to Betting Sites - but then they of course wouldn't have a CEO at the bottom layer of their wild gambling to blame for all their misfortunes.
Rose - Whal@ Lets hope 'that other company' is not where Postes vent. Not having a good day at all :)
cbb@ Great post - 100% logic that Vascepa should be a the center of solving/easing Covid longtime effects for CDV patients - as you strongly point out :)
And again - Come On Amarin: 'Get into the Game' - not missing the chance of a lifetime for this Great Drug - helping CDV patients'
hankyp@ Nothing worth fighting for is ever easy - as you put it.
But when JT ever chance he gets ' is talking about helping 'Shareholder Value' (and I believe he actually means it) - management of Amarin needs to come out of the bushes - and tell the world 'Plan B - C - if En Banc fails.
WS - needs to have 'something' to move the SP - and until now there has been absolutely 'Nothing' - besides perusing the Law process of Appeal.
Going publish: - Telling the world again' and again' what a fantastic product Vascepa is 'first approved of its kind' etc. and announcing full steam on BO / BP partner in Europe (rest of World) (I'm not talking DTC) - Public announcement's - like we have a number of investment banks working on Buy Out - to get Vascepa to the World fast as possible.
--------------
Everything announced above - is absolutely FREE. It is just feeding BIO Press - and Economical/Financial sites with News - Costs Nothing, but would have a chance of putting some 'hope' in the market for AMRN - make it a Stock to consider for investors.
And of course 'there should be reality behind the information also' - GIA in Europe is madness - everybody knows it. And putting full steam on a BO deal - is no risk at all for Amarin - in the end they themselves decides if they are going to sign a deal with a BP company - No Risk - just positive waves to send to the markets - this Stock might be worth - times 4 - 8 tomorrow - 'dare you wait to get in'?
To Amarin management: - Your Stock is in the market - 'Play the Game fellows' :)
rose@ I'm as involved as anyone - in how my future as 'not as young as I used to be' - OLD in short :)
----------------------------
I know there is many here that has really big number of shares (90 - 100 - +200.000). I'm not in that category - but still my future opportunities hangs on what happens to stock of Amarin - like many other investors here.
Let me put it like this: This Damn company better get their A** Moving. We don't have time to wait Years for things to happen.
And as with everything else in modern world, as a Business your product will never be more valuable in the future - chances are that competition passes you - if you don't forges while the iron is hot.
Amarin does (from the outside - no information) seem quite paralyzed - after rulings. But of course no one knows for sure - what is going on. We can hope that management actually are working on BO or Partner for Europe plan. That's surely what they should be doing right now - given the very small chance of En banc success.
Again and again - good news - in trial results (and SP does not react - or actually fall's as today most of the time)
-------------
The company has ever since marts 30. ruling been caught in a bad circle - that for a brief moment 'leading up to appeal' made a small move - but very fast sent back to suffering by CAFC judges hardly looking at the case.
-------------
You do have to pinch yourself in the arm - at times - trying to understand how a 'fantastic positive scientific invention - like Vascepa - can end up 'pulling thousand of loyal investors into to property (or close for many). But never the less that is what happened as a result of one 'non science educated' Judges ruling.
--------------------
I said it before - if 'T' wins the election - this story 'one form or another' has to be brought to White House and best of Fox News reporters. It will not be aloud to die.
If 'B' wins USA's economic will 'be washed to the sea' China will take over the world. Nobody will be able to afford other than bad generic copy drugs (half there already - bad drugs with often les of the active substance than Brand - soon as FDA approved). In that case neither Vascepa - or any other new invention in USA will have a chance of going anywhere.
Ok - Just noticed only the 3 valuations at the top is relevant for today (rest is from earlier this year - a diff story all together).
A bit misleading - sorry for that. So it fully correct that for now it's
Louis Chen that's the positive story with $21.
HK@ There i actually still a number of analysts (not being noticed much) having takes above $20 - and even $30:
Scroll down the page to see valuations:
https://finviz.com/quote.ashx?t=AMRN
----------------
You also working of where to go for Amarin (and where not to go)
Hope that:
1: Ideas/thoughts will be noticed at Amarin
2: Even better - that Amarin is in fact already working on plans (negations for BO - partner deal) to get things moving to get Vascepa to CDV patients of the World :)
rose@ Thanks - but have to say that there are a number of people on the board - including yourself - that would be much more qualified for such a position :)
rose@ It does become more and more obvious - that management simply has no plan for the future - at all.
--------------------
JT after loss Marts 30 - If generic get approved (and loss of appeal) - full stop to marketing USA.
Of course there is still the small hope of En Banc hearing being granted - even I'm beginning to get the feeling that CAFC 'drags the information' - keeps Amarin waiting - simply to hurt the company even further.
Judges have full immunity - and are in reality 'Gods' - that can not be touched. And for what we have seen so far happening in the 9the Circuit courts - its hard to see any support in understanding that the wrong ruling is based on fraud from generic defenders - this late in the process.
---------------------
That leaves Boy Out - soon as possible - before EU approval - as CBB and others have pointed out again' and again'.
Where we are that does seem the only thing that can/will move things for real.
If En Banc fails - a liable plan could be:
1: Stop all expenses for marketing US (building free market for generics) - meaning salesforce gone - no DTC - as JT said Amarin would react.
2: Run the US market Brand - 2 - 4 years (using every means to sue/stop generics for infringement). Later go AG in US to compete with generics.
3: A BO / or close Partner deal (with arrangement for a later BO) soon as possible before EU approval (No GIA Europe - would be a disaster - take years and years - to get moving).
4: No Form 4 for ANY - Amarin Management/Staff - before SP has passed $25 - 30.
--------------------
Feel free to Add / Remove inputs - To stop total passivity and Move forward for Amarin - to the good of both the Company and Shareholders.
xblk@ Not encouraging outlook for Amarin - from JPM. Valued as it stands hard to see the stock going anywhere (ever reaching double digits).
Reality is that Nevada wrong ruling 'killed Brand Vascepa' in USA.
------------------------
What could/can change things - make SP/Value for Company and Shareholders move North 'for real' again.
1: Patents restored by CAFC after En Banc.
2: Buy Out by Big Pharma.
--------------------------------------
Just about everything else - will be sitting on what DM calls 'Dead Money' going nowhere. Somewhat depressing on 'a seriously red day' in the Markets.
HK@ Thanks - as ever straight to the point.
--------------------------
What is always the problem with these science diagrams is' that +90% of population does not know how to read these documents (or are even given the chance).
I know you 'do everything possible' to make it as Simple and Understandable to Lay people - like me (and I think understand the basic of it - while being in this forum a lot).
--------------------------
A very Visual and Simple way 'spelling out - to lay people' - Why Vascepa - is lightyears ahead in CDV treatment compared to Lovaza - would be good - if that is even possible to do/make :)
Capt@ Thanks for settings straight - why Vascepa - is much different from Lovaza (spelled out for Lay person - like me) !
---------------------
And as I have seen people point out here in this forum. - Amarin (marketing department / sales force) ought to go trough all internet information on Lovaza (and adds from sales sites) - and ask them to correct these misinformation (treat to sue if necessary)
-------------------
Looking a the site I quoted from - as of now you do get the impression - that the 2 drugs is almost similar in function - also regarding CDV issues.
gozips@ Sharp noticed LOL - lets hope not :)
One of the best films ever - eye :)
invest83@ Your picture with the feather airborne - reminds me of the start of Forrest Gump :)
Will Vascepa ever become an adventure like that ?
Right now trying to understand the difference between drugs Lovaza and and Vacepa (not enouncing R-I trial indication).
---------------------------------
Under here how the two Drugs is descreibed at BLINK HEALTH:
About Vascepa
Icosapent ethyl is a type of omega-3 fatty acid, a fat found in fish oil. It is used along with a proper diet to help lower fats (triglycerides) in the blood. This medication is thought to work by decreasing the amount of triglycerides made by the body. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.
Icosapent ethyl is also used along with certain medications ("statins" such as atorvastatin, simvastatin) to reduce the risk of heart attack, stroke, and certain types of chest pain that require treatment in a hospital.
About Lovaza (Generic)
Omega-3 acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of a certain blood fat (triglyceride). It may also raise "good" cholesterol (HDL). In general, this drug is used after your blood fat levels have not been fully controlled by non-drug treatments (such as diet changes, exercise, decreasing alcohol intake, weight loss if overweight, controlling blood sugar if diabetic, and regulating your thyroid hormone levels).
Lowering triglycerides and increasing "good" cholesterol may help decrease the risk for strokes and heart attacks. Omega-3 acid ethyl esters are thought to work by decreasing the amount of triglyceride the body makes.
HK@ Very powerful presentation of the scientific truth - as always.
The figure of how the disaster trial ruling literally 'Killed' the Brand of Vascepa - is no exaggeration.
Capt@ Thanks for Sunday Course on the Marine historie and more.
---------------
Being a Lay person in Bio World - you kept being surprised of 'the number' and power' of the Generic Drug business.
Copying Brand owners invention in drugs has in a rather short number of years exploded into a number of Monsters Businesses like eg. Hikma and Dr. Reddy. Just see how many actually produce and sell generic Lovaza.
https://www.drugs.com/availability/generic-lovaza.html
----------------
A question to Tuccaman and Raf - regarding weekly script numbers ( Vascepa - Lovaca):
1: Are the generic scripts counted in (being labeled Lovaza) even though they are called all sort of different names in the market.
2: Where to see prices of generic's compared to Brand Lovaza ?
Cardio@ I live in Northern part of Jylland :)
Earlier post about me and wife's beach house location:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158705324
Have a nice Sunday
Jasbg
LOL - Your Welcome :)
cardio@ I observed - your Good and Serious in your pro. work in BIO.
I respect that a lot - so no more OT subjects that's not relevant on this board :)
sts@ Second that - fun at first - not any more.
So Meo - None' or new Gif - please :)
Old timers here will know story's like this one - but for many latecomers like me - it's interesting to learn about the story of also Lovaza - which seem to be linked to Amarin - the two drugs both aimed at lowering trigs - at that point in 2014.
I did not know that Lovaza is in fact a GSK product - released as early as 2004. In link below - Teva have just gotten FDA aproval for a generic Lovaza 2014 (Amarin also effected/mentioned).
http://www.pmlive.com/pharma_news/teva_launches_first_generic_of_gsks_lovaza_in_us_559273
-------------------
To finish history input - here something to cbb's (and others) augments - that company should have been sold - BO - after Approval December 2019. This article says the same at the bottom section.
http://www.pmlive.com/pharma_news/fda_okays_amarins_vascepa_for_cardiovascular_risk_reduction_1320205
funny@ It was not meant to be seen as News - merely as good links to lot of 'selected' information on the drug - and drugs general.
Sorry if I made it look/sound like New' News :)
News of Generic Vascepa - is out - Stores are waiting:
A generic version of Vascepa has been approved by the FDA. However we either do not have pricing information for it, or it is not commercially available. More info: generic Vascepa availability
Should maybe point out - that the Org. case Amarin vs. Hikma/Dr Reddy was in District of Nevada:
https://en.wikipedia.org/wiki/United_States_District_Court_for_the_District_of_Nevada
Appeal in CAFC 9th Circuit September 2. 2020.
Meo@ You 'shoot with sharp ammunition here' - and is 'sadly' Right - it isolated is not JT's fault - the faulty ruling - that killed the stock.
What in hindsight has been pointed out here numerous times is the absolutely 'in sane' choice of 9th Circuit. The most liberal Court in the USA. Just about any other court - the outcome would have been in favor of Amarin - and the world would have been a much different place for Shareholders.
In both 9th and 6th - scroll down to see who appointed the judges
Explains eg. why the 9th Circuit have been at war with president T all the way.
https://en.wikipedia.org/wiki/United_States_Court_of_Appeals_for_the_Ninth_Circuit
----------------------
The 6th Circuit is a completely other ballgame - again scroll down and see who appointed the judges.
https://en.wikipedia.org/wiki/United_States_Court_of_Appeals_for_the_Sixth_Circuit
Jasbg
NB - the complete list of Circuits:
https://en.wikipedia.org/wiki/List_of_courts_of_the_United_States
Map of Circuits - scroll down (click pic left)
https://en.wikipedia.org/wiki/United_States_courts_of_appeals
BB@ Think I understand - you meant 'talking Law' :)
The light not always - 'that bright :)
For every major event in live of individuals - or life of companies - there are Windows of opportunity.
--------------------------
For young boys and girls - Windows in teenage years - can follow you rest of your life (positive - negative) in relation to partner (not making the right move - when opportunity was there).
--------------------------
No different for a One Drug (vulnerable) Company like Amarin. You have to Move when 'time is right' or you will be overtaken - and loose value.
--------------------------
Amarin and current management 'have tried' to be market darlings' - in weeks after Reduce It trial announced September 2018. The value of company and SP just vent up' - and up' - something above 700% at the top.
Here was the WINDOW - for selling to Big Pharma - as many have pointed out in hindsight. Had the company been sold in a BO at that point to BP - the sales today could have been +500% easy' - and the SP would have been $80 - 100 - where many expected it to be today.
--------------------------
Well - BO in the PERFECT Window - did not happen (you did not score the dream girl/boy of your life) - life vent On.
But even you did not made 'the perfect score' (personally - company) - marrying the 'down to earth reliable partner' - in the end maybe saved you a lot of heartache later in life :)
---------------------------
Here is where the analogy becomes challenged'. Can only hope Amarin now Understand Reality - and 'given the next chance' TO MOVE - at the right opportunity - company will do everything to make sure that Vascepa is 'Brought to the World' - while at the same time rewarding Long time Shareholders - for their support for Years and Years :)
Jasbg
-------------------